Changes

However, Michael Hansen points out that every single one of the GE diploid salmon and all but 2 of the GE triploid salmon showed mean allergenic potencies higher than the highest value for non-GE diploid salmon. Coupling this point along with the small sample size of the study, Hansen feels there is good cause to perform another, more comprehensive study.

The FDA concluded that "The allergenic potency of triploid ABT salmon is not significantly different from that of sponsor control diploid salmon. There is insufficient data and information to draw a conclusion on the allergenic potency of diploid ABT salmon."